Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.66

+0.5%

12:22 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8000)	3/11/2003 7:38:33 PM
From: JMarcus	of 52153

EPIX had good volume on today's spike. In the last 52 weeks the stock has only traded above 1M shares on one occasion: 7/31/02. Today's volume, 172,575 shares, was the 5th highest volume since then, and the highest since 10/14/02, when 223,600 shares were traded. The daily average is just 24,045 shares. Dr. Ron Garren's article appeared in Biospace.com this week at biospace.com. I wasn't buying any stock today, so maybe I'm not the only one reading his stuff <g>. Regarding market potential for just the angiogram procedure (EPIX is targeting other procedures as well), EPIX's website has this to say in its FAQs: <<We believe that MS-325 has the potential to replace the over five million diagnostic angiograms were performed in the United States in 1999 at a total cost to the healthcare system of over $9 billion. The number of diagnostic angiograms performed in the U.S. has been steadily increasing over the past five years and is expected to continue the same upward trend.>> Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next